Unity Biotechnology Ownership
| UBX Stock | USD 1.14 0.02 1.72% |
Shares in Circulation | First Issued 2017-03-31 | Previous Quarter 16.8 M | Current Value 16.8 M | Avarage Shares Outstanding 7.4 M | Quarterly Volatility 5.3 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Unity |
Unity Stock Ownership Analysis
About 21.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 1.39. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Unity Biotechnology recorded a loss per share of 1.28. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 20th of October 2022. Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California. Unity Biotechnology operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 65 people. For more information please call Anirvan Ghosh at 650 416 1192 or visit https://unitybiotechnology.com.Besides selling stocks to institutional investors, Unity Biotechnology also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Unity Biotechnology's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Unity Biotechnology's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Unity Biotechnology Quarterly Liabilities And Stockholders Equity |
|
Only 1.3% of Unity Biotechnology are currently held by insiders. Unlike Unity Biotechnology's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Unity Biotechnology's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Unity Biotechnology's insider trades
Unity Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Unity Biotechnology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Unity Biotechnology backward and forwards among themselves. Unity Biotechnology's institutional investor refers to the entity that pools money to purchase Unity Biotechnology's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Wells Fargo & Co | 2024-06-30 | 43.4 K | Cercano Management Llc | 2024-06-30 | 41.2 K | State Street Corp | 2024-06-30 | 37.8 K | Bridgeway Capital Management, Llc | 2024-06-30 | 25 K | Commonwealth Equity Services Inc | 2024-06-30 | 24.6 K | Northern Trust Corp | 2024-09-30 | 22.5 K | Susquehanna International Group, Llp | 2024-06-30 | 17.8 K | Endowment Wealth Management, Inc. | 2024-09-30 | 13.5 K | Advisor Group Holdings, Inc. | 2024-06-30 | 13.1 K | Arch Venture Corp | 2024-09-30 | 1 M | Alyeska Investment Group, L.p. | 2024-06-30 | 920 K |
Unity Biotechnology Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Unity Biotechnology insiders, such as employees or executives, is commonly permitted as long as it does not rely on Unity Biotechnology's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Unity Biotechnology insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Unity Biotechnology Outstanding Bonds
Unity Biotechnology issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Unity Biotechnology uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Unity bonds can be classified according to their maturity, which is the date when Unity Biotechnology has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Unity Stock Analysis
When running Unity Biotechnology's price analysis, check to measure Unity Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Unity Biotechnology is operating at the current time. Most of Unity Biotechnology's value examination focuses on studying past and present price action to predict the probability of Unity Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Unity Biotechnology's price. Additionally, you may evaluate how the addition of Unity Biotechnology to your portfolios can decrease your overall portfolio volatility.